Search Results - Evans, Jeffrey TR

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Abstract 5440: Study of the mechanism of action and pharmacodynamic response of JNJ-26481585, a potent histone deacetylase inhibitor in the setting of melanoma

    Abstract 5440: Study of the mechanism of action and pharmacodynamic response of JNJ-26481585, a potent histone deacetylase inhibitor in the setting of melanoma by Poele, Robert Te, Heaton, Simon, Garrett, Michelle, Hellemans, Peter, Hickson, Ian, Sand-Dejmek, Janna, Evans, Jeffrey TR, de Bono, Johann S., Banerji, Udai

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Synthesis of diaryl ethers through the copper-promoted arylation of phenols with arylboronic acids. An expedient synthesis of thyroxine

    Synthesis of diaryl ethers through the copper-promoted arylation of phenols with arylboronic acids. An expedient synthesis of thyroxine by Evans, David A, Katz, Jeffrey L, West, Theodore R

    Published in Tetrahedron letters
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Abstract B049: Phase II study of NUC-3373, leucovorin, irinotecan (NUFIRI) + bevacizumab vs FOLFIRI + bevacizumab for the second-line treatment of patients with advanced/metastatic  colorectal cancer (NuTide:323)

    Abstract B049: Phase II study of NUC-3373, leucovorin, irinotecan (NUFIRI) + bevacizumab vs FOLFIRI + bevacizumab for the second-line treatment of patients with advanced/metastatic... by Wilson, Richard H, Ciombor, Kristen K, Coveler, Andrew L, Graham, Janet S, Schlechter, Benjamin L, George, Thomas J, Élez, Elena, Evans, TR Jeffry, Berlin, Jordan, de Gramont, Aimery, McKissock, Fiona G, Oelmann, Elisabeth, Bloss, Jeffrey D, Martini, Giulia, Bennouna, Jaafar, Modest, Dominik P, Taieb, Julien, Tabernero, Josep

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Abstract C032: NUC-7738 in combination with pembrolizumab in patients with metastatic melanoma: Phase 2 results from the NuTide:701 study

    Abstract C032: NUC-7738 in combination with pembrolizumab in patients with metastatic melanoma: Phase 2 results from the NuTide:701 study by Blagden, Sarah P, Symeonides, Stefan N, Skolariki, Aglaia, Haris, Noor Md, Boh, Zhuang, Um, In Hwa, Elshani, Mustafa, Dickson, Alison L, Zhang, Ying, Harrison, David J, McKissock, Fiona G, Oelmann, Elisabeth, Bloss, Jeffrey D, Cook, Natalie, Evans, TR Jeffry, Plummer, E. Ruth

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: